Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].

Zhonghua yi xue za zhi - 3 Sept 2024

Wang X T, Kang Y, Wang H Y, Shi W W, Xiao Y, Liu Y H, Si J M, Li S L, Jin J J

Abstract excerpt

Objective: To summarize and analyze the clinical characteristics and prognosis of thoracic SMARCA4-deficient undifferentiated tumor (SMARCA4-UT). Methods: A retrospective analysis was conducted on the clinical data of 51 patients with SMARCA4-UT who were diagnosed in the First Affiliated Hospital of Zhengzhou University from January 2018 to December 2023, and 52 patients with SMARCA4-intact non-small cell lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Kaplan-Meier Estimate

Share to Lung Neoplasms

Share to Nuclear Proteins

Share to Prognosis

Share to Transcription Factors

Source

Identifiers

PMID: 39193606
DOI: 10.3760/cma.j.cn112137-20240417-00902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].PMID 39193606Read ↗

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read ↗

[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].Semantic proximity Read ↗

Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go.Semantic proximity Read ↗

Defining the first bona fide cell model for SMARCA4-deficient, undifferentiated tumor.Semantic proximity Read ↗

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors.Semantic proximity Read ↗

Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4- deficent thoracic tumorsSemantic proximity Read ↗

Establishment and characterization of TRI-LC21: a novel patient-derived cell line of SMARCA4-deficient undifferentiated thoracic tumor.Semantic proximity Read ↗

[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].Semantic proximity Read ↗

[Clinicopathological analysis of SMARCA4-deficient tumors of digestive system origin].Semantic proximity Read ↗

Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case SeriesSemantic proximity Read ↗

SMARCA4-deficient thoracic malignancies with small cell lung cancer-like features: A clinicopathological and molecular study of a heterogeneous group.Semantic proximity Read ↗

Clinical features and prognostic biomarkers of patients with the rare SMACRA4 gene mutation in non-small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.